Investing in a Healthier Future: How Atalan Is Enabling Health Systems to Predict and Prevent Surprise Resignations and Protect Revenue

Atalan is Pioneering the Clinician Retention Intelligence (CRI) Category in Healthcare

Healthcare systems thrive when clinicians do. Atalan, a healthcare workforce technology company, is leading the way in helping hospitals and health systems protect revenue, retain clinicians, and sustain high-quality patient care. With over 60% of physicians and nearly half of all nurses reporting symptoms of burnout, costing U.S. healthcare systems more than $4.6 billion annually in turnover and lost productivity, the need for action is clear. Atalan's healthcare workforce intelligence platform enables hospitals and health systems to predict and prevent avoidable clinician turnover up to 12 months in advance. With new backing from BioAdvance Capital, Atalan is scaling its impact, turning today's crisis into tomorrow's opportunity for a healthier, more sustainable healthcare system.

Proactively Supporting Workforce Well-Being

Healthcare organizations are facing unprecedented clinician shortages, shrinking margins, and rising burnout. Atalan partners with hospitals and health systems to strengthen workforce sustainability. Using real-time, objective electronic health record (EHR) and human resources information system (HRIS) data, Atalan identifies who is at risk, why, and what to do about it.

Atalan's predictive analytics platform taps into the data hospitals already have to spot at-risk providers early, pinpoint the causes, and recommend targeted interventions - before turnover disrupts care or drains resources. The results speak for themselves. In real-world deployments, Atalan's platform has reduced turnover in critical departments by more than 10% and significantly improved the efficacy of staff interventions - clear indicators of healthier, more productive clinical environments.

"Healthcare systems are navigating a perfect storm of workforce shortages, financial pressures, and clinician burnout," said Tiffany Chan, CEO and Co-Founder of Atalan. "At Atalan, we believe the solution lies in turning data into foresight, leveraging the wealth of information already within health systems to anticipate which clinicians are at risk of leaving and why. By providing clear, actionable recommendations well before resignations happen, we help organizations not only retain their talent but also safeguard the quality of care and financial health of the health system, shifting from reactive to proactive workforce management."

From Complex Data to Smart Decisions

What distinguishes Atalan is its ability to turn fragmented operational data into a forward-looking workforce strategy. The platform's predictive models track patterns in the work environment, workload volatility and intensity, and care team dynamics to reveal where pressure is building and how leaders can respond before it becomes a crisis.

"Burnout is too often viewed as a personal failing, when in truth it's a systemic issue that demands systemic solutions," said Sisi Hu, Ph.D., Chief Wellbeing Economist and Co-Founder of Atalan. "We created Atalan to equip leaders with the solutions to intervene early - before stress becomes suffering, and before talented clinicians resign. Data is not just for measuring performance; it can be a powerful tool for solving."

Why We're Investing in Atalan

"We see Atalan as uniquely positioned at the intersection of real-world impact, technical feasibility, and unmet market demand," said Shahram Hejazi, Ph.D., CEO of BioAdvance.

"What makes this investment particularly compelling is the manageable nature of the AI challenge Atalan addresses. Unlike many early-stage AI companies that require vast datasets and highly customized models, Atalan works with well-validated predictors of burnout already documented in the literature. That means it can deliver accurate, actionable outputs from a relatively small volume of data, making it cost-effective and scalable."

Atalan addresses a clear and pressing need: helping health systems manage costs while maintaining quality of care. Productivity and clinical excellence are deeply intertwined, and Atalan provides a path to achieving both by focusing on clinician well-being.

"You could look at Atalan as a tool to avoid burnout," said BioAdvance Partner, David Shin, M.D., "but we see it as a way to enable sustainable financial health for hospitals and health systems. This shift from reactive support to proactive design is what health systems need now more than ever."

Evidence-Based Practice, Delivered at Scale

Atalan does not stop at identifying problems; it guides health systems through solving them. Its platform is rooted in peer-reviewed research and incorporates proven strategies for clinician well-being and workforce design. Recommendations are data-driven and tailored to each organization's culture and operations, ensuring solutions are practical and sustainable.

Clients have implemented impactful changes, including introducing technological solutions to reduce documentation burden and more frequent targeted check-ins with clinicians. One system reported a 12:1 return on investment within 12 months, driven by reduced turnover and improved operational efficiency.

A Stronger System Starts with a Supported Workforce

As the healthcare sector faces rising demand and financial constraints, clinician well-being has emerged as a strategic imperative. Atalan represents a new generation of healthcare innovation - one that uses data not to monitor turnover after it happens, but to prevent it before it begins.

With support from BioAdvance Capital, Atalan is helping to build a more resilient healthcare system.

BioAdvance is a regionally focused, evergreen fund created to accelerate transformative innovation in human life sciences. It invests in early-stage companies that are developing cutting-edge therapeutics, digital health solutions, devices, and diagnostics in the Mid-Atlantic region of the US. By supporting entrepreneurs in these companies, and with decades of scientific and industry experience, BioAdvance helps bring disruptive technologies to market-advancing patient care, improving health outcomes, and opening doors to follow-on funding through venture and public capital, strategic partnerships, grants, and acquisitions.